Allowing pharmacists to prescribe biosimilars could save hundreds of millions of euros

The Irish Pharmacy Union estimates that €370m has been lost in potential savings since 2017. File Picture.

Not allowing pharmacists to substitute expensive biological medicines with more cost-effective alternatives is a “missed opportunity” for the State to save hundreds of millions of euros.

The Irish Pharmacy Union has estimated that €370m in potential savings has already been lost since 2017.